Organizer

Summit Background

Growing at a CAGR of around 6%, the global pharmaceutical market is forecasted to reach US$ 1043.4 Billion by 2012. However, it is expected that the growth will slow down in near future due to patent expiration of key drugs and increased prevalence of generics. It is therefore more important than ever that pharma manufacturers should optimize their manufacturing line for cost reduction while following latest standards, like CGMP, QbD and PAT concepts etc.

A large untapped population and strong economic growth in major countries are expected to make Asia-Pacific the most lucrative pharmaceutical market in future. Growing by 20% per year. China is expected to be the third largest pharma market by 2013. However, the lack of manufacturing technologies and streamlined & consistent global supply network still are key hindrances for many local companies' development. To help national pharma manufacturers enter the global market, currently Chinese government is drafting new GMP standards which is expected to be released in this first half year. Making a thorough understanding of this vital policy and the pharma market itself is critical for doing successful business in China.

The summit will provide you a unique platform for first hand information of newly released policies by face to face contact with competent authorities. World-leading pharma manufacturers will share with you their successful experience and lessons through keynote speeches and real-life case study. In addition, the summit will be a valuable opportunity for your networking with business partners and potential clients.